Chengda Pharmaceutical announced that the company's board of directors recently received a written resignation report from Deputy General Manager Peng Zhiyong. Due to personal reasons, Peng Zhiyong applied to resign as the company's deputy general manager. After his resignation, he did not hold any positions in the company or holding subsidiaries. His original term of office expired on November 11, 2028, and the resignation report took effect when it was delivered to the company's board of directors. Peng Zhiyong has completed the handover of work, which will not affect the normal production and operation of the company. As of the disclosure date of the announcement, Peng Zhiyong indirectly held a total of 386,000 shares of the company, accounting for 0.25% of the company's total share capital. After leaving office, his shares will continue to fulfill relevant commitments and comply with share change management regulations.

Chengda Pharmaceutical announced that the company's board of directors recently received a written resignation report from Deputy General Manager Peng Zhiyong. Due to personal reasons, Peng Zhiyong applied to resign as the company's deputy general manager. After his resignation, he did not hold any positions in the company or holding subsidiaries. His original term of office expired on November 11, 2028, and the resignation report took effect when it was delivered to the company's board of directors. Peng Zhiyong has completed the handover of work, which will not affect the normal production and operation of the company. As of the disclosure date of the announcement, Peng Zhiyong indirectly held a total of 386,000 shares of the company, accounting for 0.25% of the company's total share capital. After leaving office, his shares will continue to fulfill relevant commitments and comply with share change management regulations.